2.60
-0.07 (-2.62%)
-0.07 (-2.62%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaccinex Inc | VCNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.07 | -2.62% | 2.60 | 19:42:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.7689 | 2.51 | 2.85 | 2.55 | 2.67 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.53 | 2.60 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,170 | 1,337,296 | $ 2.60 | $ 3,473,804 | 453,305 | 1.63 - 12.23 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:43:18 | 77 | $ 2.60 | USD |
Vaccinex Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 58.20M | 22.39M | 12.36M | $ 523.00k | $ - | -2.50 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 1.10% |
Vaccinex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VCNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.59 | 2.85 | 2.36 | 2.55 | 409,751 | 0.01 | 0.39% |
| 1 Month | 2.25 | 2.85 | 2.00 | 2.37 | 396,952 | 0.35 | 15.56% |
| 3 Months | 1.77 | 3.21 | 1.64 | 2.21 | 624,301 | 0.83 | 46.89% |
| 6 Months | 8.00 | 8.389 | 1.63 | 2.70 | 731,257 | -5.40 | -67.5% |
| 1 Year | 5.22 | 12.23 | 1.63 | 3.78 | 500,735 | -2.62 | -50.19% |
| 3 Years | 12.00 | 12.23 | 1.63 | 3.91 | 215,924 | -9.40 | -78.33% |
| 5 Years | 12.00 | 12.23 | 1.63 | 3.91 | 215,924 | -9.40 | -78.33% |
Vaccinex Description
| Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15) Neurology, VX5 Autoimmune, and others. |
